ESSA Industries Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? ESSA Industries Indonesia Tbk. trades at Rp655 (market cap 11.37T, 45.96M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: ESSA Industries Indonesia Tbk. is far larger — about 69.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and ESSA Industries Indonesia Tbk. is more actively traded (45.96M versus 62.5K). Which is the better fit depends on your goals.
| ESSA | OBAT | |
|---|---|---|
Market Cap | 11.37T | 164.65B |
Volume | 45.96M | 62.5K |
Lot | 459.58K | 625 |
Turnover | 30.1B | 15.03M |
Average Price | 654.93 | 240.55 |
Value | 30.1B | 15.03M |
Indicative Equilibrium Price | 655 | 238 |
Indicative Equilibrium Volume | 14.53K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
Surya Esa Perkasa, PT (the company) was established based on the Notarial Deed No. 7 dated March 24, 2006 of Hasbullah Abdul Rasyid SH., M.Kn, public notary in Jakarta, within the framework of Domestic Capital Law No. 6 year 1968 Jo Law No. 12 year 1970.
Read more on ESSA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →